These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20504468)

  • 1. Pyroglutamyl peptidase II, a thyrotropin releasing hormone degrading enzyme: purification and specificity studies of the rabbit brain enzyme.
    Wilk S; Wilk EK
    Neurochem Int; 1989; 15(1):81-9. PubMed ID: 20504468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone-degrading enzyme in human serum is classified as type II of pyroglutamyl aminopeptidase: influence of thyroid status.
    Yamada M; Mori M
    Proc Soc Exp Biol Med; 1990 Sep; 194(4):346-51. PubMed ID: 1975097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of a highly specific pyroglutamyl aminopeptidase type-II from the membrane fraction of bovine brain.
    Gallagher SP; O'Connor B
    Int J Biochem Cell Biol; 1998 Jan; 30(1):115-33. PubMed ID: 9597758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide-specific peptidases: does brain contain a specific TRH-degrading enzyme?
    Wilk S
    Life Sci; 1986 Oct; 39(17):1487-92. PubMed ID: 3093794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices.
    Charli JL; Mendez M; Vargas MA; Cisneros M; Assai M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1989 Oct; 14(3):191-6. PubMed ID: 2575716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
    Cummins PM; O'Connor B
    Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine brain pyroglutamyl aminopeptidase (type-1): purification and characterisation of a neuropeptide-inactivating peptidase.
    Cummins PM; O'Connor B
    Int J Biochem Cell Biol; 1996 Aug; 28(8):883-93. PubMed ID: 8811836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
    Busby WH; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone.
    Bauer K; Nowak P; Kleinkauf H
    Eur J Biochem; 1981 Aug; 118(1):173-6. PubMed ID: 6116600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification and some properties of pyroglutamyl peptidase from Enterococcus faecalis.
    Mineyama R; Saito K
    Microbios; 1998; 94(377):47-62. PubMed ID: 9785485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism.
    Salers P; Ouafik LH; Giraud P; Dutour A; Maltese JY; Oliver C
    Mol Cell Biochem; 1991 Jul; 106(1):15-24. PubMed ID: 1681421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
    Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
    J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.
    Møss J; Bundgaard H
    Pharm Res; 1990 Jul; 7(7):751-5. PubMed ID: 2118634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of copper(II) to thyrotropin-releasing hormone (TRH) and its analogs.
    Meng R; Becker J; Lin FT; Saxena S; Weber SG
    Inorganica Chim Acta; 2005 Jun; 358(10):2933-2942. PubMed ID: 17160139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of pyroglutamyl peptidase II, a specific TRH degrading enzyme in rabbit retinal membranes and in human retinoblastoma cells.
    Wilk S; Suen CS; Wilk EK
    Neuropeptides; 1988 Jul; 12(1):43-7. PubMed ID: 2901687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of a membrane bound pyroglutamyl amino peptidase degrading thyrotropin releasing hormone in rat brain.
    Garat B; Miranda J; Charli JL; Joseph-Bravo P
    Neuropeptides; 1985 Mar; 6(1):27-40. PubMed ID: 2859545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of prolyl endopeptidase, pyroglutamyl peptidase I, TRH, and its metabolites in rat pancreas.
    Salers P; Ouafik LH; Giraud P; Maltese JY; Dutour A; Oliver C
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E845-50. PubMed ID: 1352085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.